Sitagliptin is an oral medication that treats type 2 diabetes by inhibiting the enzyme dipeptidyl peptidase-4. 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-triazolo[3-a]pyrazine hydrochloride is a chemical intermediate employed to synthesize the drug Sitagliptin phosphate.
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
| API Name | Sitagliptin |
|---|---|
| CAS No | 762240-92-6 |
| Molecular Formula | C6H8ClF3N4 |
| Molecular Weight | 228.60 g/mol |
| Synonyms | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine;hydrochloride |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Sitagliptin is an oral medication that treats type 2 diabetes by inhibiting the enzyme dipeptidyl peptidase-4. 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-triazolo[3-a]pyrazine hydrochloride is a chemical intermediate employed to synthesize the drug Sitagliptin phosphate.
The CAS number of 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride is 762240-92-6.
The molecular formula of 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride is C6H8ClF3N4.
The listed molecular weight of 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride is 228.60 g/mol.
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride is listed as being used in connection with the following API: Sitagliptin.
The listed synonym or IUPAC name for 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride is 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine;hydrochloride.